Clinical Trial

A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Study acronym: China-CHAMP
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A randomized, double-blind, placebo-controlled, multicenter, phase III clinical study of the efficacy and safety of two low-concentration atropine sulfate eye drops in slowing the progression of myopia in children
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-06; most recent amendment 2025-07-25.
Trial Details
NCT Number NCT06209320
Lead Sponsor Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Conditions Myopia
Enrollment 777 participants
Start Date 2022-03-15
Primary Completion 2025-03-21 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-07-30